APA (7th ed.) Citation

WC, L., XR, Z., YJ, L., CT, C., CY, W., FI, L., . . . HD, W. (2022). Therapeutic potential of nanoceria pretreatment in preventing the development of urological chronic pelvic pain syndrome: Immunomodulation via reactive oxygen species scavenging and SerpinB2 downregulation. Bioengineering & translational medicine, 8(1), e10346. https://doi.org/10.1002/btm2.10346

Chicago Style (17th ed.) Citation

WC, Lien, Zhou XR, Liang YJ, Ching CT, Wang CY, Lu FI, Chang HC, Lin FH, and Wang HD. "Therapeutic Potential of Nanoceria Pretreatment in Preventing the Development of Urological Chronic Pelvic Pain Syndrome: Immunomodulation via Reactive Oxygen Species Scavenging and SerpinB2 Downregulation." Bioengineering & Translational Medicine 8, no. 1 (2022): e10346. https://doi.org/10.1002/btm2.10346.

MLA (9th ed.) Citation

WC, Lien, et al. "Therapeutic Potential of Nanoceria Pretreatment in Preventing the Development of Urological Chronic Pelvic Pain Syndrome: Immunomodulation via Reactive Oxygen Species Scavenging and SerpinB2 Downregulation." Bioengineering & Translational Medicine, vol. 8, no. 1, 2022, p. e10346, https://doi.org/10.1002/btm2.10346.